Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort ; volume:12 ; number:12 ; day:15 ; month:11 ; year:2023 ; pages:2807-2817 ; date:12.2023
Infectious diseases and therapy ; 12, Heft 12 (15.11.2023), 2807-2817, 12.2023
- Urheber
-
Sension, Michael G.
Brunet, Laurence
Hsu, Ricky K.
Fusco, Jennifer S.
Cochran, Quateka
Uranaka, Christine
Sridhar, Gayathri
Vannappagari, Vani
Wyk, Jean Van
McCurdy, Lewis
Wohlfeiler, Michael B.
Fusco, Gregory P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-023-00890-2
- URN
-
urn:nbn:de:101:1-2024030721132120229658
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sension, Michael G.
- Brunet, Laurence
- Hsu, Ricky K.
- Fusco, Jennifer S.
- Cochran, Quateka
- Uranaka, Christine
- Sridhar, Gayathri
- Vannappagari, Vani
- Wyk, Jean Van
- McCurdy, Lewis
- Wohlfeiler, Michael B.
- Fusco, Gregory P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The cost associated with administering risperidone long-acting injections in the Australian community
Long-Acting Reversible Contraception
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Creation of a long-acting nanoformulated dolutegravir
Implications of long-acting antiretrovirals (LAARVs) for HIV treatment in Sub-Saharan Africa
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
The cost associated with administering risperidone long-acting injections in the Australian community
Long-Acting Reversible Contraception
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Creation of a long-acting nanoformulated dolutegravir
Implications of long-acting antiretrovirals (LAARVs) for HIV treatment in Sub-Saharan Africa
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
The cost associated with administering risperidone long-acting injections in the Australian community
Long-Acting Reversible Contraception
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Creation of a long-acting nanoformulated dolutegravir
Implications of long-acting antiretrovirals (LAARVs) for HIV treatment in Sub-Saharan Africa